2 citations
,
January 2019 This review discusses autoimmune skin disorders, including lupus erythematosus and scleroderma, and their common treatments, reporting no new clinical results.
1 citations
,
September 2024 in “IP Indian Journal of Clinical and Experimental Dermatology” This source discusses the potential of topical JAK inhibitors, like tofacitinib, as effective treatments for autoimmune skin diseases, emphasizing their superior safety profile and minimal adverse effects compared to conventional systemic therapies.
1 citations
,
April 2024 in “Indian Journal of Pharmacy Practice” This source discusses autoimmune disorders, noting that the presence of autoantibodies can precede disease development, especially in genetically predisposed individuals, with various triggers like vitamin D deficiency and UV exposure potentially influencing onset and severity.
January 2022 in “Medical research archives” This article reviews the potential role of vitamin D supplementation as an adjunct to alemtuzumab therapy in multiple sclerosis management, noting its possible benefits for autoimmune comorbidities and patient adherence, but reports no new clinical results.
3 citations
,
May 2020 in “Gynecology Obstetrics and Reproductive Medicine” In this study, no association was found between bacterial vaginosis and skin disorders in patients with autoimmune antibody positivity.